SPG7突变 - 新型表型呈现模仿特异性帕金森病的表现
Karri Madhavi1, Rukmini Mridula Kandadai1, Sruthi Kola1
1Department of Parkinson's and Movement Disorders Research Centre (PDMDRC), Citi Neuro Centre, Banjara Hills, Hyderabad, Telangana, India.
Clinical parkinsonism & related disorders
|December 3, 2024
概括
SPG7基因突变可以导致早期发病的帕金森病,模仿特异性帕金森病,即使没有家族病史. 与SPG7相关的帕金森症患者对多巴胺治疗有积极反应.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- SPG7基因的突变与神经退行性疾病有关.
- 帕金森症是一种复杂的神经系统疾病,其特征是运动症状.
- 早期发病的帕金森病 (EOPD) 在50岁之前出现,并且可以有不同的遗传原因.
研究的目的:
- 在SPG7突变的个体中调查帕金森症的临床表现和遗传基础.
- 评估在早期发病的帕金森症中考虑SPG7突变的诊断实用性.
- 评估SPG7相关帕金森症患者对多巴胺类药物的治疗反应.
主要方法:
- 对已证实有SPG7突变,呈现帕金森特征的患者的回顾性分析.
- 运动症状的临床评估,包括不对称性和对levodopa的反应.
- 家庭病史的审查和排除帕金森病的其他已知的遗传原因.
主要成果:
- SPG7突变可以表现为不对称的帕金森症,非常类似于特异性帕金森病.
- 在早期发病的帕金森病中,SPG7突变的存在应考虑,不论家族病史如何.
- 与SPG7突变相关的帕金森症对多巴胺激素治疗表现出良好的中度反应.
结论:
- SPG7突变代表了早期帕金森症的重要遗传原因.
- 对SPG7突变的诊断考虑对于EOPD中准确的诊断和遗传咨询至关重要.
- 多巴胺治疗可以有效地管理SPG7相关帕金森症的运动症状.
更多相关视频
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
15.0K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.4K
相关概念视频
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
